🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

Cells(2023)10.3390/cells12151956Source: DataRank Database

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk is a research paper published in Cells (2023). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (14 grants)Impact (FWCI 0.70)OA: goldTopics (84)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (52)

Roberto Corchado‐Cobos ORCID,Adrián Blanco‐Gómez ORCID,Natalia García‐Sancha ORCID,Sonia Castillo‐Lluva ORCID,Ana Martín‐Garcia ORCID

Live enrichment

PubMed:37566035 PMC:PMC10417374 OpenAlex:https://openalex.org/W4385346855

MCIN/AEI/10.13039/501100011039

Grant: PID2020-118527RB-I00

MCIN/AEI/10.13039/501100011039

Grant: PDC2021-121735-I00

MCIN/AEI/10.13039/501100011039

Grant: CSI144P20

MCIN/AEI/10.13039/501100011039

Grant: PIE14/00066

MCIN/AEI/10.13039/501100011039

Grant: PI18/01242

MCIN/AEI/10.13039/501100011039

Grant: PT17/0019

MCIN/AEI/10.13039/501100011039

Grant: RTI2018-094130-B-100

MCIN/AEI/10.13039/501100011039

Grant: BC190820

MCIN/AEI/10.13039/501100011039

Grant: R01CA184476

MCIN/AEI/10.13039/501100011039

Grant: DE AC02-05CH11231

MCIN/AEI/10.13039/501100011039

Grant: PT17/0019/0023

MCIN/AEI/10.13039/501100011039

Grant: HR18-00304

MCIN/AEI/10.13039/501100011039

Grant: 12-2016 IGP

National Institutes of Health

Grant: 1R01CA184476-01A1

Molecular and Therapeutic Basis of Morphometric Aberrations in Brain Tumors

FWCI

0.70

Citation Percentile

0.7%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/12/15/1956/pdf?version=1690536975

publisherhttps://www.mdpi.com/2073-4409/12/15/1956/pdf?version=1690536975

publisherhttps://www.mdpi.com/2073-4409/12/15/1956/pdf

journalhttps://doi.org/10.3390/cells12151956

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37566035

Fields of Study

Chemotherapy-induced cardiotoxicity and mitigationPARP inhibition in cancer therapyCardiovascular Function and Risk Factors0301 basic medicine0303 health sciences03 medical and health sciencesFemaleAnimalsMiceCardiotoxicityAnthracyclinesGenetic MarkersAntibiotics, AntineoplasticNeoplasmsPhenotype

MeSH Terms

AnimalsAntibiotics, AntineoplasticFemaleGenetic MarkersNeoplasmsPhenotypeAnthracyclinesMiceCardiotoxicity

Keywords

BiologyQuantitative trait locusCardiotoxicityGeneticsGeneQuantitative trait lociAnthracyclinesComplex Genetic DiseaseIntermediate Molecular PhenotypesBiomedical and clinical sciences24 Ciencias de la VidaARCHITECTURESSUSCEPTIBILITYCardiovascularMicesitios genéticosTUMORAntibioticsMISSING HERITABILITYNeoplasms2.1 Biological and endogenous factorsCancerAntibiotics, AntineoplasticBiological SciencesCHEMOTHERAPYAntineoplasticHeart DiseasePhenotype3209 FarmacologíaFemaleLife Sciences & BiomedicineEXPRESSIONGenetic MarkersantraciclinasOncology and Carcinogenesis616-006.04610ArticleBreast CancerAnimalsGenetic Predisposition to DiseaseGenetic TestingScience & TechnologyCARDIOMYOPATHYQH573-671EARLY BREAST-CANCERCOMPLEX TRAITS31 Biological sciencesHuman Genomepredisposición genética a la enfermedadCell Biology32 Biomedical and clinical sciencesHUMAN HEART4.1 Discovery and preclinical testing of markers and technologiesCiencias BiomédicasGenetic LociWomen's HealthanimalesHuman medicineCytology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being